Shawn Tomasello Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Shawn Tomasello.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Shawn Tomasello. Shawn Tomasello is Director in ABEONA THERAPEUTICS INC. ($AKC) and Chief Commercial Officer in PHARMACYCLICS INC ($PCYC) and Chief Commercial Officer in Kite Pharma, Inc. ($KITE) and Director in Principia Biopharma Inc. ($PRNB) and Director in Diplomat Pharmacy, Inc. ($DPLO) and Director in 4D Molecular Therapeutics Inc. ($FDMT) and Director in UroGen Pharma Ltd. ($URGN) and Director in TCR2 THERAPEUTICS INC. ($TCRR).
Latest Insider Trading Transactions of Shawn Tomasello
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FDMT, AKC, DPLO, KITE, PCYC, PRNB, TCRR, URGN
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 19 2021 | FDMT | 4D Molecular Thera ... | Tomasello Shawn | Director | Option Exercise | A | 26.89 | 22,500 | 605,025 | 22,500 | |
Feb 04 2021 | TCRR | TCR2 THERAPEUTICS ... | Tomasello Shawn | Director | Option Exercise | A | 26.33 | 4,177 | 109,980 | 4,177 | |
Feb 04 2021 | TCRR | TCR2 THERAPEUTICS ... | Tomasello Shawn | Director | Option Exercise | A | 26.33 | 15,191 | 399,979 | 15,191 | |
Sep 28 2020 | PRNB | Principia Biopharm ... | Tomasello Shawn | Director | Option Exercise | D | 62.66 | 10,240 | 641,638 | 0 | |
Sep 28 2020 | PRNB | Principia Biopharm ... | Tomasello Shawn | Director | Option Exercise | D | 36.79 | 20,475 | 753,275 | 0 | |
Jun 10 2020 | URGN | UroGen Pharma Ltd. | Tomasello Shawn | Director | Option Exercise | A | 28.24 | 10,000 | 282,400 | 10,000 | |
Jun 08 2020 | PRNB | Principia Biopharm ... | Tomasello Shawn | Director | Option Exercise | A | 62.66 | 10,240 | 641,638 | 10,240 | |
May 22 2020 | AKC | ABEONA THERAPEUTIC ... | Tomasello Shawn | Director | Option Exercise | A | 3.20 | 43,035 | 137,712 | 43,035 | |
May 22 2020 | AKC | ABEONA THERAPEUTIC ... | Tomasello Shawn | Director | Grant | A | 0.00 | 35,938 | 0 | 35,938 | 0 to 35.9 K |
Feb 10 2020 | DPLO | Diplomat Pharmacy, ... | Tomasello Shawn | Director | Sell | D | 4.00 | 33,259 | 133,036 | 0 | 33.3 K to 0 (-100.00 %) |
Feb 10 2020 | DPLO | Diplomat Pharmacy, ... | Tomasello Shawn | Director | Sell | U | 4.00 | 11,278 | 45,112 | 33,259 | 44.5 K to 33.3 K (-25.32 %) |
Oct 04 2019 | DPLO | Diplomat Pharmacy, ... | Tomasello Shawn | Director | Sell | S | 4.84 | 859 | 4,158 | 44,537 | 45.4 K to 44.5 K (-1.89 %) |
Aug 30 2019 | PRNB | Principia Biopharm ... | Tomasello Shawn | Director | Option Exercise | A | 36.79 | 10,240 | 376,730 | 10,240 | |
Aug 30 2019 | PRNB | Principia Biopharm ... | Tomasello Shawn | Director | Option Exercise | A | 36.79 | 20,475 | 753,275 | 20,475 | |
Aug 30 2019 | PRNB | Principia Biopharm ... | Tomasello Shawn | Director | Option Exercise | A | 36.79 | 10,240 | 376,730 | 10,240 | |
Aug 30 2019 | PRNB | Principia Biopharm ... | Tomasello Shawn | Director | Option Exercise | A | 36.79 | 20,475 | 753,275 | 20,475 | |
Jun 05 2019 | URGN | UroGen Pharma Ltd. | Tomasello Shawn | Director | Option Exercise | A | 34.83 | 10,000 | 348,300 | 10,000 | |
Jun 05 2019 | DPLO | Diplomat Pharmacy, ... | Tomasello Shawn | Director | Sell | S | 4.85 | 1,274 | 6,185 | 45,396 | 46.7 K to 45.4 K (-2.73 %) |
Jun 05 2019 | DPLO | Diplomat Pharmacy, ... | Tomasello Shawn | Director | Grant | A | 0.00 | 33,259 | 0 | 46,670 | 13.4 K to 46.7 K (+248.00 %) |
Jun 05 2019 | DPLO | Diplomat Pharmacy, ... | Tomasello Shawn | Director | Sell | S | 4.85 | 1,274 | 6,185 | 45,396 | 46.7 K to 45.4 K (-2.73 %) |
Jun 05 2019 | DPLO | Diplomat Pharmacy, ... | Tomasello Shawn | Director | Grant | A | 0.00 | 33,259 | 0 | 46,670 | 13.4 K to 46.7 K (+248.00 %) |
Oct 03 2018 | DPLO | Diplomat Pharmacy, ... | Tomasello Shawn | Director | Grant | A | 0.00 | 2,275 | 0 | 13,411 | 11.1 K to 13.4 K (+20.43 %) |
Jun 05 2018 | DPLO | Diplomat Pharmacy, ... | Tomasello Shawn | Director | Sell | S | 24.27 | 1,680 | 40,766 | 11,136 | 12.8 K to 11.1 K (-13.11 %) |
Jun 05 2018 | DPLO | Diplomat Pharmacy, ... | Tomasello Shawn | Director | Grant | A | 0.00 | 3,654 | 0 | 12,816 | 9.2 K to 12.8 K (+39.88 %) |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Option Exercise | D | 46.09 | 38,500 | 1,774,465 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Option Exercise | D | 63.87 | 67,000 | 4,279,290 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Option Exercise | D | 63.87 | 93,000 | 5,939,910 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Sell | D | 0.00 | 39,933 | 0 | 0 | 39.9 K to 0 (-100.00 %) |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Sell | U | 180.00 | 16,135 | 2,904,300 | 39,933 | 56.1 K to 39.9 K (-28.78 %) |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Gift | G | 0.00 | 5,000 | 0 | 56,068 | 61.1 K to 56.1 K (-8.19 %) |
Sep 27 2017 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Sell | S | 179.66 | 4,203 | 755,127 | 61,068 | 65.3 K to 61.1 K (-6.44 %) |
Sep 27 2017 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Grant | A | 0.00 | 4,500 | 0 | 65,271 | 60.8 K to 65.3 K (+7.40 %) |
Jun 05 2017 | DPLO | Diplomat Pharmacy, ... | Tomasello Shawn | Director | Grant | A | 0.00 | 4,722 | 0 | 9,162 | 4.4 K to 9.2 K (+106.35 %) |
Dec 27 2016 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Option Exercise | A | 46.09 | 38,500 | 1,774,465 | 38,500 | |
Dec 27 2016 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Grant | A | 0.00 | 10,600 | 0 | 60,235 | 49.6 K to 60.2 K (+21.36 %) |
Dec 22 2016 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Sell | S | 50.86 | 4,901 | 249,265 | 49,635 | 54.5 K to 49.6 K (-8.99 %) |
Jun 02 2016 | DPLO | Diplomat Pharmacy, ... | Tomasello Shawn | Director | Grant | A | 0.00 | 1,483 | 0 | 4,440 | 3 K to 4.4 K (+50.15 %) |
Dec 21 2015 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Option Exercise | A | 63.87 | 160,000 | 10,219,200 | 160,000 | |
Dec 21 2015 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Grant | A | 0.00 | 44,000 | 0 | 54,000 | 10 K to 54 K (+440.00 %) |
Oct 09 2015 | DPLO | Diplomat Pharmacy, ... | Tomasello Shawn | Director | Grant | A | 0.00 | 2,957 | 0 | 2,957 | 0 to 3 K |
May 28 2015 | PCYC | PHARMACYCLICS INC | Tomasello Shawn | Chief Commercial Of ... | Option Exercise | D | 121.89 | 100,000 | 12,189,000 | 0 | |
May 28 2015 | PCYC | PHARMACYCLICS INC | Tomasello Shawn | Chief Commercial Of ... | Sell | U | 261.25 | 32 | 8,360 | 0 | 32 to 0 (-100.00 %) |
May 28 2015 | PCYC | PHARMACYCLICS INC | Tomasello Shawn | Chief Commercial Of ... | Sell | U | 261.25 | 61 | 15,936 | 0 | 61 to 0 (-100.00 %) |
May 28 2015 | PCYC | PHARMACYCLICS INC | Tomasello Shawn | Chief Commercial Of ... | Sell | U | 261.25 | 109 | 28,476 | 0 | 109 to 0 (-100.00 %) |
May 28 2015 | PCYC | PHARMACYCLICS INC | Tomasello Shawn | Chief Commercial Of ... | Sell | U | 261.25 | 7,302 | 1,907,648 | 0 | 7.3 K to 0 (-100.00 %) |
May 28 2015 | PCYC | PHARMACYCLICS INC | Tomasello Shawn | Chief Commercial Of ... | Sell | D | 261.25 | 50,000 | 13,062,500 | 7,302 | 57.3 K to 7.3 K (-87.26 %) |
Nov 20 2014 | PCYC | PHARMACYCLICS INC | Tomasello Shawn | Chief Commercial Of ... | Sell | D | 138.37 | 5,390 | 745,801 | 57,110 | 62.5 K to 57.1 K (-8.62 %) |
Aug 19 2014 | PCYC | PHARMACYCLICS INC | Tomasello Shawn | Chief Commercial Of ... | Option Exercise | A | 121.89 | 100,000 | 12,189,000 | 100,000 | |
Aug 19 2014 | PCYC | PHARMACYCLICS INC | Tomasello Shawn | Chief Commercial Of ... | Grant | A | 0.00 | 62,500 | 0 | 62,500 | 0 to 62.5 K |
Page: 1